Onkologie und Hämatologie | Zeitschrift memo - Magazine of European Medical Oncology Ausgabe 2/2011 Inhaltsverzeichnis ( 20 Artikel ) 01.06.2011 | Editorial | Ausgabe 2/2011 Gastrointestinal cancers – still many questions to be resolved E. Wöll 01.06.2011 | Editorial | Ausgabe 2/2011 ASH 2010: new drugs and novel therapeutic concepts on the move M. Steurer 01.06.2011 | CECOG News | Ausgabe 2/2011 CECOG/BC1.2.001 – International Clinical Trials Workshop, July 1–2, Cluj-Napoca Dagmar Just 01.06.2011 | Review | Ausgabe 2/2011 Current treatment strategies of oesophageal carcinoma T. Ruhstaller, M. Stahl 01.06.2011 | Review | Ausgabe 2/2011 Gastric cancer – still many questions to be solved F. Lordick, G. Schumacher, M. Becker-Schiebe 01.06.2011 | Short Review | Ausgabe 2/2011 Recent developments and future perspectives in the systemic treatment of metastatic colorectal cancer O. Coutelle, M. Hallek, U. T. Hacker 01.06.2011 | Short Review | Ausgabe 2/2011 Bowel First? Simultaneous Resection? Liver First? Treatment options in patients with colorectal cancer and resectable synchronous liver metastases M. Zitt 01.06.2011 | Short Review | Ausgabe 2/2011 Can stereotactic radiofrequency ablation replace liver resection? R. Bale, G. Widmann 01.06.2011 | Short Review | Ausgabe 2/2011 Adjuvant chemotherapy in colon carcinoma stages II and III G. Resch, J. Thaler 01.06.2011 | Short Review | Ausgabe 2/2011 (Neo-)Adjuvant radiochemotherapy in stage II/III rectal cancer W. Hoffmann, F. Lordick, M. Becker-Schiebe 01.06.2011 | Short Review | Ausgabe 2/2011 Recent advances and future challenges in the treatment of hepatocellular and biliary tract carcinomas D. Koeberle, P. Samaras 01.06.2011 | Short Review | Ausgabe 2/2011 Side effect management during treatment of gastrointestinal (GI) cancers M. Becker-Schiebe, F. Lordick, W. Hoffmann 01.06.2011 | Short Review | Ausgabe 2/2011 Contribution of PET-CT in the management of gastrointestinal cancer M. Gabriel 01.06.2011 | ASH Report | Ausgabe 2/2011 Novel Developments in AML – ASH 2010 W. R. Sperr, P. Valent 01.06.2011 | ASH Report | Ausgabe 2/2011 Myelodysplastic Syndromes (MDS) – News from ASH 2010 T. Nösslinger, M. Pfeilstöcker 01.06.2011 | ASH Report | Ausgabe 2/2011 Indolent lymphomas and mantle cell lymphoma: New developments as of ASH 2010 J. Drach 01.06.2011 | ASH Report | Ausgabe 2/2011 Multiple myeloma at ASH 2010: Some points that might change our daily practice E. Gunsilius, W. Willenbacher 01.06.2011 | ASH Report | Ausgabe 2/2011 ASH update 2010: Chronic lymphocytic leukaemia M. Steurer, S. Schmidt 01.06.2011 | ASH Report | Ausgabe 2/2011 Novel agents in diffuse large B-cell lymphoma: A short update including ASH 2010 T. Melchardt, S. W. Hofbauer, R. Greil, G. Hopfinger 01.06.2011 | ASH Report | Ausgabe 2/2011 What's new in CML? Highlights of ASH 2010 J. Rudzki, D. Wolf
